XJPX2533
Market cap133mUSD
Jan 21, Last price
372.00JPY
1D
1.09%
1Q
-10.41%
Jan 2017
42.86%
Name
Oenon Holdings Inc
Chart & Performance
Profile
Oenon Holdings, Inc. develops alcoholic beverages, food products, enzymes and pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, chu-hi, sake, sake compounds, umeshu plum wine, processed liquor, wine, brewing and industrial alcohol, seasonings, and other products. It also manufacture and sell enzymes for food and industrial use comprising lactase, a lactose hydrolytic enzyme; cellulase, a dietary fiber processing enzyme; glucose isomelase, a fructose corn syrup manufacturing enzyme; protease, a proteolytic enzyme; dispase, a cell dispersion enzyme; and isoamylase, a starch processing enzyme. In addition, the company offers active pharmaceutical ingredients, such as Pravastatin for hyperlipidemia treatment; Voglibose for diabetes mellitus treatment; starch for food processing; and diagnostic medicines and health foods. Further, it sells and leases real estate properties. Additionally, the company engages in transportation and cargo handling, and other activities. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 84,947,000 4.72% | 81,120,000 3.18% | |||||||
Cost of revenue | 76,122,000 | 76,866,000 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 8,825,000 | 4,254,000 | |||||||
NOPBT Margin | 10.39% | 5.24% | |||||||
Operating Taxes | 206,000 | 664,000 | |||||||
Tax Rate | 2.33% | 15.61% | |||||||
NOPAT | 8,619,000 | 3,590,000 | |||||||
Net income | 3,393,000 -335.46% | (1,441,000) -581.94% | |||||||
Dividends | (294,000) | (438,000) | |||||||
Dividend yield | 1.43% | 2.88% | |||||||
Proceeds from repurchase of equity | (349,000) | ||||||||
BB yield | 2.29% | ||||||||
Debt | |||||||||
Debt current | 3,356,000 | 7,023,000 | |||||||
Long-term debt | 1,919,000 | 2,518,000 | |||||||
Deferred revenue | 5,000 | ||||||||
Other long-term liabilities | 4,916,000 | 4,860,000 | |||||||
Net debt | 1,343,000 | 7,097,000 | |||||||
Cash flow | |||||||||
Cash from operating activities | 4,606,000 | (860,000) | |||||||
CAPEX | (871,000) | (3,947,000) | |||||||
Cash from investing activities | 11,000 | (4,040,000) | |||||||
Cash from financing activities | (4,688,000) | 4,809,000 | |||||||
FCF | 11,270,000 | 202,000 | |||||||
Balance | |||||||||
Cash | 828,000 | 899,000 | |||||||
Long term investments | 3,104,000 | 1,545,000 | |||||||
Excess cash | |||||||||
Stockholders' equity | 18,544,000 | 15,929,000 | |||||||
Invested Capital | 32,342,000 | 24,782,000 | |||||||
ROIC | 30.18% | 15.78% | |||||||
ROCE | 27.16% | 17.08% | |||||||
EV | |||||||||
Common stock shares outstanding | 58,210 | 59,244 | |||||||
Price | 354.00 37.74% | 257.00 -28.61% | |||||||
Market cap | 20,606,340 35.34% | 15,225,708 -28.84% | |||||||
EV | 22,795,340 | 24,159,708 | |||||||
EBITDA | 10,678,000 | 5,988,000 | |||||||
EV/EBITDA | 2.13 | 4.03 | |||||||
Interest | 91,000 | 79,000 | |||||||
Interest/NOPBT | 1.03% | 1.86% |